• PDF: Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)

Global Bio-Pharma CMO Market Report

  • Publication Date:May 2010
  • Publisher:Koncept Analytics
  • Product Type: Report
  • Pages:32

Global Bio-Pharma CMO Market Report

The big-pharma companies are increasingly outsourcing their production of drugs to contract manufacturing organizations (CMOs) solely to reduce cost of production, working capital requirement, and time-to-market, or to obtain a specific expertise not available in-house. The biggest factor to drive the growth of CMOs in the pharmaceutical industry is the growing need of state-of-the-art process & production technologies, which have proven highly effective in meeting regulatory requirements.

The global market for bio-pharma has grown at a CAGR of 11.2% over the last few years. The share of the CMO market of the total bio-pharma market has also increased over 2001 to -2008. The Bio-Pharma CMO market can be segmented into Mammalian CMO market and Microbial CMO market. The largest capacity share of the bio-pharma CMO market is held by the Mammalian CMO market.

The main growth driver of the bio-pharma CMO market is the increasing outsourcing trend among the bio-pharma manufacturers as a result of stringent regulatory environment. However, factors like global economic crisis, intellectual property risk, increasing regulatory cost, and lack of integrated CMOs are also acting as a roadblock in the path of overall industry growth, which are highly recommended to be solved to grow in the long term.

The current report analyzes the global bio-pharma CMO market. The various drivers, opportunities and the challenges faced by the market are discussed in detail. The competitive aspect of the market is also highlighted and the key players are profiled with their strategies for this market.

By combining SPSS Inc.'s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

  • 1. Overview
    • 1.1 Global Pharmaceutical Market
      • Market Size
      • Breakdown by Region
    • 1.2 Global Bio-Pharmaceutical Market
      • Market Size
      • Breakdown by Segments
    • 1.3 Global Contract Outsourcing Market
      • Market Size
      • Value Chain
  • 2. Global CMO Bio-Pharma Market
    • 2.1 Overview
    • 2.2 Market Size
    • 2.3 Segmentation
      • 2.3.1 Mammalian CMO Market
      • 2.3.2 Microbial CMO Market
  • 3. India- Outsourcing Hub
    • 3.1 Overview
    • 3.2 India's Advantage
      • 3.2.1 Cost Efficiency Attractiveness
      • 3.2.2 Skilled Manpower
      • 3.2.3 USFDA approved plants
      • 3.2.4 Vertical Integration
    • 3.3 Key Issues
      • 3.3.1 IP Risk Perception Limiting Growth
      • 3.3.2 Regulatory Environment
      • 3.3.3 High Tax Rates
  • 4. Market Movements
    • 4.1 Key Trends
      • 4.1.1 Trends in Outsourcing to Asia
      • 4.1.2 Growing Share of Bio-Pharma market
      • 4.1.3 Declining Internal Manufacturing Capacity
    • 4.2 Growth Drivers
      • 4.2.1 Growing World Population
      • 4.2.2 Bio-Pharma Companies facing Cost cutting pressures
      • 4.2.3 Growth in Asia/Africa/Australia markets
      • 4.2.4 Growing Generics Market
    • 4.3 Challenges
      • 4.3.1 Weakening of Outsourcing Trend
      • 4.3.2 Intellectual Property Risk
      • 4.3.3 Increasing Regulatory Costs
      • 4.3.4 Lack of Integrated CMOs
  • 5. Competitive Landscape
    • 5.1 Industry-wide Bio-Pharma Capacity Distribution
    • 5.2 Cell Culture Bioreactor Capacity Distribution
  • 6. Company Profiles
    • 6.1 Lonza
      • Overview
      • Key Financials
      • Business Strategies
      • Re-Engineering Lonza
      • Focus on Increasing Capacity in Bio-Pharma
    • 6.2 Jubilant Organosys
      • Overview
      • Key Financials
      • Business Strategies
      • Integrated Business Model
      • Increasing Organizational Efficiencies
    • 6.3 Piramal Healthcare
      • Overview
      • Key Financials
      • Business Strategies
      • Acquisition Led Growth Strategy
      • Increasing Focus on Custom Manufacturing
    • 6.4 Patheon Inc.
      • Overview
      • Key Financials
      • Business Strategies
      • Focus on Operational Efficiency
      • Increasing Market Share
  • 7. Market Outlook
    • 7.1 Market Forecast
    • 7.2 Forecast Methodology
      • 7.2.1 Dependent and Independent Variables
      • 7.2.2 Correlation Analysis
      • 7.2.3 Regression Analysis
  • List of Tables
    • Dependent & Independent Variables, 2001- 2009
    • Correlation Matrix
    • Model Summary - Coefficient of Determination
    • Regression Coefficients Output
  • List of Figures
    • Global Pharmaceutical Market, 2003-2008
    • Global Pharmaceutical Market by Region, 2008
    • Global Bio-Pharmaceutical Market, 2002-2008
    • Bio-Pharmaceutical Commercial Product Sales, 2002-2008
    • Global Pharmaceutical Contract Outsourcing Market, 2007-2008
    • Utilization of Outsourcing across Value Chain
    • Global CMO Bio-Pharma Market Size, 2000-2009
    • Segmentation of Bio-Pharma CMO Market
    • Mammalian Cell Culture Capacity, 2006-2009E
    • Microbial CMO Market by Capacity (Fermenter Volume), 2003-2009E
    • Indian Custom Manufacturing Outsourcing Market, 2007-2010E
    • Cost Efficiency Attractiveness in India
    • Skilled Manpower Attractiveness in India
    • No. of USFDA Approved Plants Comparison
    • Regulatory Environment Attractiveness in India
    • Comparison of Corporate Income Tax Rates by Country
    • Trend in Outsourcing to Asia, 2009
    • Bio-Pharma CMO Market Share, 2001 & 2008
    • Declining Internal Custom Manufacturing Capacity
    • World Population, 2000-2009
    • Pharma Market Potential Growth by Region, 2009-2013
    • Global Generic Market, 2008-2014
    • Global Bio-Pharma Industry Capacity Distribution, 2009
    • CMO & PDC Cell Culture Bioreactor Capacity distribution, 2004-2008
    • Lonza Business Revenues, 2005-2009
    • Jubilant Organosys Business Revenues, 2005-2009
    • Piramal Healthcare Business Revenues, 2005-2009
    • Patheon Business Revenues, 2005-2009
    • Global Bio-Pharma CMO Market Forecast, 2009-2013F
+44 20 8816 8548

Ask a question about Global Bio-Pharma CMO Market Report

Enter the characters you see in the picture below
Captcha